STENHOUSE MARK (Chief Operating Officer) received a stock award from PROMETHEUS BIOSCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/13/2022ACC: 0001209191-22-061090
Officer· Chief Operating Officer
Since Mar 2021
+43.90K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
43.90K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9.81K
Price / share
—
Trade value
—
% of position
59.0%
12/9/2022
16.63K→26.44K
Total
Net shares
+9.81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2022 | A · Award | +9.81K | — | — | 59.0% | 16.63K | 26.44K |
| Total | +9.81K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
34.09K shares
Shares
+34.09K
Strike price
110.20
Held after
34.09K
Exercisable
—
12/9/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock34.09K shares | 12/9/2022 | A · Award | +34.09K | 110.20 | — | 34.09K |